174 related articles for article (PubMed ID: 7476310)
1. Free insulin-like growth factors in human obesity.
Frystyk J; Vestbo E; Skjaerbaek C; Mogensen CE; Orskov H
Metabolism; 1995 Oct; 44(10 Suppl 4):37-44. PubMed ID: 7476310
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
[TBL] [Abstract][Full Text] [Related]
3. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children.
Park MJ; Kim HS; Kang JH; Kim DH; Chung CY
J Pediatr Endocrinol Metab; 1999; 12(2):139-44. PubMed ID: 10392359
[TBL] [Abstract][Full Text] [Related]
5. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
6. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children.
Saitoh H; Kamoda T; Nakahara S; Hirano T; Nakamura N
Clin Endocrinol (Oxf); 1998 Apr; 48(4):487-92. PubMed ID: 9640416
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
Benbassat CA; Maki KC; Unterman TG
J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
[TBL] [Abstract][Full Text] [Related]
9. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
Skjaerbaek C; Frystyk J; Møller J; Christiansen JS; Orskov H
Eur J Endocrinol; 1996 Dec; 135(6):672-7. PubMed ID: 9025711
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein (IGFBP)-3-bound IGF-I and IGFBP-3-bound IGF-II in growth hormone deficiency.
Belgorosky A; Rivarola MA
Horm Res; 1999; 52(2):60-5. PubMed ID: 10681634
[TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
Attia N; Tamborlane WV; Heptulla R; Maggs D; Grozman A; Sherwin RS; Caprio S
J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
[TBL] [Abstract][Full Text] [Related]
12. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
[TBL] [Abstract][Full Text] [Related]
13. Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion.
Martinelli CE; Keogh JM; Greenfield JR; Henning E; van der Klaauw AA; Blackwood A; O'Rahilly S; Roelfsema F; Camacho-Hübner C; Pijl H; Farooqi IS
J Clin Endocrinol Metab; 2011 Jan; 96(1):E181-8. PubMed ID: 21047921
[TBL] [Abstract][Full Text] [Related]
14. Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.
Jørgensen JO; Vahl N; Hansen TB; Skjaerbaek C; Fisker S; Orskov H; Hagen C; Christiansen JS
Clin Endocrinol (Oxf); 1998 Apr; 48(4):479-86. PubMed ID: 9640415
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
17. The effect of growth hormone on bioactive IGF in overweight/obese women.
Dichtel LE; Bjerre M; Schorr M; Bredella MA; Gerweck AV; Russell BM; Frystyk J; Miller KK
Growth Horm IGF Res; 2018 Jun; 40():20-27. PubMed ID: 29679919
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.
Donahue LR; Beamer WG
J Endocrinol; 1993 Jan; 136(1):91-104. PubMed ID: 7679139
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
[TBL] [Abstract][Full Text] [Related]
20. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
